Premeal injection of rapid-acting insulin reduces postprandial glycemic excursions in type 1 diabetes.
about
Insulin Aspart in the Management of Diabetes Mellitus: 15 Years of Clinical ExperienceMulticenter closed-loop/hybrid meal bolus insulin delivery with type 1 diabetes.Day and night closed-loop control in adults with type 1 diabetes: a comparison of two closed-loop algorithms driving continuous subcutaneous insulin infusion versus patient self-managementPharmacokinetic and Pharmacodynamic Properties of Faster-Acting Insulin Aspart versus Insulin Aspart Across a Clinically Relevant Dose Range in Subjects with Type 1 Diabetes Mellitus.Suspension of basal insulin to avoid hypoglycemia in type 1 diabetes treated with insulin pump.Insulin initiation and intensification in patients with T2DM for the primary care physician.Reduction of postprandial glycemic excursions in patients with type 1 diabetes: a novel human insulin formulation versus a rapid-acting insulin analog and regular human insulin.Preliminary evaluation of a new semi-closed-loop insulin therapy system over the prandial period in adult patients with type 1 diabetes: the WP6.0 Diabeloop studyFeasibility of a bihormonal closed-loop system to control postexercise and postprandial glucose excursionsFaster-acting insulin aspart: earlier onset of appearance and greater early pharmacokinetic and pharmacodynamic effects than insulin aspart.Improved Postprandial Glycemic Control with Faster-Acting Insulin Aspart in Patients with Type 1 Diabetes Using Continuous Subcutaneous Insulin Infusion.A Pooled Analysis of Clinical Pharmacology Trials Investigating the Pharmacokinetic and Pharmacodynamic Characteristics of Fast-Acting Insulin Aspart in Adults with Type 1 Diabetes.Recognition, prevention, and proactive management of hypoglycemia in patients with type 1 diabetes mellitus.Ultrafast-acting insulins: state of the artTowards a Physiological Prandial Insulin Profile: Enhancement of Subcutaneously Injected Prandial Insulin Using Local Warming Devices.Continuous subcutaneous insulin infusion therapy and multiple daily insulin injections in type 1 diabetes mellitus: a comparative overview and future horizons.Short acting insulin analogues in intensive care unit patients.Comparing the efficacy, safety, and utility of intensive insulin algorithms for a primary care practice.Comment on: Luijf et al. Premeal Injection of rapid-acting insulin reduces postprandial glycemic excursions in type 1 diabetes. Diabetes Care 2010;33:2152-2155.Subcutaneous injection versus subcutaneous infusion of insulin: are the rates of absorption truly the same?Efficacy and safety of fast-acting insulin aspart in comparison with insulin aspart in type 1 diabetes (onset 1): a 52-week, randomized, treat-to-target, phase 3 trial.Optimal prandial timing of bolus insulin in diabetes management: a review.A 7-year follow-up retrospective, international, multicenter study of insulin pump therapy in children and adolescents with type 1 diabetes.Pathophysiology of postprandial hyperglycaemia in women with type 1 diabetes during pregnancy.U-100, pH-Neutral formulation of VIAject(®) : faster onset of action than insulin lispro in patients with type 1 diabetes.Response to Comment on: Luijf et al. Premeal Injection of Rapid-Acting Insulin Reduces Postprandial Glycemic Excursions in Type 1 Diabetes. Diabetes Care 2010;33:2152–2155.
P2860
Q28085428-850EB94E-939F-458D-9DFA-8BDB1DCB874DQ30370610-DA4B8B75-7EC7-426E-B979-2068B6505692Q30409243-0841425F-593F-42A9-95F7-AFF32A52C5C0Q33658772-6B32C5F9-EAE3-44F4-8DEB-E9C094E0251AQ34850888-095E664F-7C0C-4147-9B9C-EC54E804CB7AQ35115106-1846D8CC-C9D6-4F0D-B291-2FE98118266DQ35337607-D353CDCB-C813-476B-AB01-192195E9FAE3Q35682897-0C810843-2A79-49ED-B0E5-0DC8EBE65A81Q36605718-B951DE8B-16A7-4A0B-B3BA-CC802A2C9038Q37320243-BB30FDBF-6139-4610-B588-61C80F3F1FDCQ37595832-B9B27D76-882F-4716-8125-FA6801774679Q37742600-F9AB683F-9DCF-4CCA-89F5-B5003C2A5278Q37890782-2BF514A2-5A12-485D-98AD-B8AD704EE2E8Q38037727-F465745B-7E28-410E-8B8D-6972C74F6485Q38578266-3FFA56A4-6A0C-4948-80B5-96DADB77262AQ38652925-1F19939A-1298-417D-B7D5-8B6356875669Q40743447-8D2C72D4-3703-44DE-8429-B21F374E88E1Q42286699-3A3E0FDB-36C2-4727-B2FA-AEA2D712F9B6Q42576531-6FF273A5-04B2-4FBC-ABD6-7472C23ED235Q42959127-13A67881-1BD8-47B6-A0D3-0BFA6081A0BDQ47188954-131C8896-2D9C-4129-8D21-2D4C01B939EAQ47769561-C365C62C-39F7-48F3-A5E3-6E4D918412FDQ50987466-7A6AA6A1-3688-4865-8226-25C0D5823476Q50994002-62CAA9E0-A542-42B2-9C8C-80E863F4B9C9Q51367050-BB502392-BD1D-4AA6-921C-3660DCBEE0DCQ55464193-84D8DF83-E4B8-45BA-BD2B-0696AADAAEFB
P2860
Premeal injection of rapid-acting insulin reduces postprandial glycemic excursions in type 1 diabetes.
description
2010 nî lūn-bûn
@nan
2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Premeal injection of rapid-act ...... excursions in type 1 diabetes.
@ast
Premeal injection of rapid-act ...... excursions in type 1 diabetes.
@en
Premeal injection of rapid-act ...... excursions in type 1 diabetes.
@nl
type
label
Premeal injection of rapid-act ...... excursions in type 1 diabetes.
@ast
Premeal injection of rapid-act ...... excursions in type 1 diabetes.
@en
Premeal injection of rapid-act ...... excursions in type 1 diabetes.
@nl
prefLabel
Premeal injection of rapid-act ...... excursions in type 1 diabetes.
@ast
Premeal injection of rapid-act ...... excursions in type 1 diabetes.
@en
Premeal injection of rapid-act ...... excursions in type 1 diabetes.
@nl
P2860
P356
P1433
P1476
Premeal injection of rapid-act ...... excursions in type 1 diabetes
@en
P2093
Arianne C van Bon
Joost B Hoekstra
P2860
P304
P356
10.2337/DC10-0692
P407
P577
2010-08-06T00:00:00Z